Wednesday Dec 06, 2006
By The WaveStrength Team
Merck & Co. Inc. (MRK:NYSE) guidance is guiding the whole pharma sector into a dark hole, including WaveStrength Options Weekly short candidate Pfizer Inc. (PFE: NYSE). Funny that it's working out that way: Merck is still trying to get around the unfortunate "undue mortality events" surrounding Vioxx, which is exactly what Pfizer discovered with its new cholesterol drug. Needless to say, WOW readers' PFE puts are on the move too, and may actually beat Monday's max gain of 221%.
More tonight... Now there's no doubt that Yahoo! Inc. (YHOO:NASDAQ) has officially declared “war” on its biggest competition Google Inc. (GOOG:NASDAQ). YHOO is shuffling management to become more efficient at its business. The company is reorganizing into three different units: one focused on Yahoo!'s audience, one focused on advertisers, and one focused on technological research and development. Daniel Rosensweig, COO since 2003, has “departed” from the company, and Susan Decker, CFO, will head the advertising unit. Investors are little fazed this morning by the news: YHOO is trading down $0.21 below its 10-day Moving Average, in the flat trend it has called home since early November.
This morning, bankrate.com is reporting that the 30-year fixed, the 15-year fixed, the 5/1 ARM, the 30-year fixed jumbo, and even the 5/1 jumbo ARM are all falling.
This broad-based rate drop is once again providing a lift to the housing sector, as reduced rates spark new buying activity. That's always positive, especially for the basket of homebuilding stocks Adam and I are holding in our WaveStrength Options Weekly service. As I write, our streetTRACKS SPDR Homebuilders (XHB) calls are on the verge of breaking to a new high - and our WOW readers are positioned to profit off each and every up-tick!
============================================================= Copyright 2006 by The Taipan Group,LLC. All rights are reserved. Printed in USA. Information, opinion, research, and commentary contained herein is obtained from sources believed to be reliable; their reliability, however, cannot be guaranteed. The maxim of Caveat Emptor applies - let the buyer beware! WaveStrength Market Report does not provide individual investment advice, or act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Investments recommended in this service should be made only after consulting with your investment advisor, and only after reviewing the prospectus or financial statements of the company.
WaveStrength Market Report reserves the right to use email endorsements and/or profit claims from its subscribers for marketing purposes. All names will be kept anonymous and only subscriber's initials will be used unless express written permission has been granted to the contrary.
The Taipan Group, LLC.expressly forbids its writers from having a financial interest in any security that they recommend to their readers. Furthermore, all employees and agents of The Taipan Group, LLC and its affiliate companies must wait 24 hours before following an initial recommendation published on the Internet, or 72 hours after a printed publication is mailed.

|